Haleon


Haleon on-track to deliver healthy and steady shareholder returns

15/04/24 -"Notably, since its demerger, Haleon has remained focused on reducing its debt (2023 adjusted net debt/EBITDA of 2.9x vs. 3.5x in 2022), thanks to healthy cash generation. More importantly, besides a ..."

Pages
53
Language
English
Published on
15/04/24
You may also be interested by these reports :
29/04/24
Despite the challenging environment, Unilever had a strong start to the year buoyed by the Prestige and Wellbeing segments. With its FY 24 outlook ...

25/04/24
Reckitt reported a strong set of figures for Q1 24, beating on growth across segments. Revenue was up 1.5%, easily outperforming expectations. ...

24/04/24
Bic’s Q1 performance was largely in line with the market’s expectations. The strong momentum in the stationery and shavers segments was offset by ...

19/04/24
L’Oréal has once again reported a strong start to the year, with all divisions exceeding expectations. The robust demand from global consumers for ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO